Plunging Johnson & Johnson Vaccine Supply Dents State Inoculation Efforts
By BY SHARON LAFRANIERE, NOAH WEILAND AND JENNIFER STEINHAUER
U.S.
https://ift.tt/323t2W6
With supplies from Johnson & Johnson set to fall 86 percent, a White House official warned that the vaccine would be scarce until a troubled Baltimore plant gains regulatory approval.
New York Times
Vaccination and Immunization, Drugs (Pharmaceuticals), United States Politics and Government, Coronavirus (2019-nCoV), Factories and Manufacturing
April 9, 2021 at 11:20PM